Genocea receives welcome cash boost from Gates Foundation
Genocea Biosciences, a clinical-stage company advancing T cell vaccines for infectious diseases, has raised $30 million in new funding.
Read MoreAuthor: Ben Adams
Prostate Cancer UK launches its ‘MANifesto’
A host of celebrities and royals are backing a campaign by a new UK charity to raise awareness about prostate cancer.
Read MoreUK to showcase dementia research capabilities
The UK government is bringing together life sciences leaders to promote the UK’s dementia research facilities, while also seeking to nurture global collaboration against the disease.
Read MoreComms agencies prepare for Dragons’ Den style competition
Twelve UK communication agencies have been nominated by their pharma partners for this year’s Marketing Communications Agency Team of the Year awards, run by PharmaTimes.
Read MoreUK stem cell pioneer shares Nobel Prize in Medicine
John Gurdon from the UK and Shinya Yamanaka from Kyoto University in Japan have both taken the Nobel Prize in Medicine or Physiology for their work in stem cell research.
Read More- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
